<$BlogRSDUrl$> Marcus P. Zillman, M.S., A.M.H.A. Author/Speaker/Consultant
Marcus P. Zillman, M.S., A.M.H.A. Author/Speaker/Consultant
Internet Happenings, Events and Sources


Thursday, September 24, 2009  



Molecular Oncology
http://www.molecularoncology.org/

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. Topics include:

* Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
* Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
* Biomarkers: diagnosis, prognosis, stratification and efficacy.
* Cancer genetics, epigenetics, and genomic instability.
* Minimal residual disease, pre-malignant lesions.
* Cancer micro-environment.
* Molecular pathology.
* Tumour immunology.
* Translational research.
* Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).
* Chemotherapy, radiotherapy and surgery.
* Clinical pharmacology.
* Clinical trials, integration of basic science into cancer clinical trials.
* Epidemiology and prevention.
* Infrastructures (biobanks, databases, genomic resources).

A main feature of the Journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders. Coverage: Reviews, original articles, technical notes, editorials, news & views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements, advertisements.

posted by Marcus Zillman | 4:31 AM
archives
subject tracers™